The International Diabetes Federation welcomes these additions, which mark a breakthrough in recognising the growing burden of diabetes globally, with an estimated 590 million people living with the condition in 2024.
POWERFUL INGREDIENTS: Metabolaid is a breakthrough blend of polyphenols derived from Lemon Verbena and Hibiscus that promotes appetite control through activating the AMPK pathway, your metabolic masterswitch
Liraglutide retains a role for GI-sensitive individuals and those who benefit from daily dose control, but for the majority of people seeking GLP-1 therapy, semaglutide's superior efficacy, convenience, and cost-effectiveness make it the default choice
What you can do: Click here to learn more about this from the FDA.
Either way, it's not something any of us should be aspiring to do
But, recently, some studies have found that these drugs may be of benefit for people with MS